Publications and Academic Activities

Publications on Robot-Assisted Surgery (RAS)

Academic Activities Related to RAS

Publications on Other Topics (2009- )

Academic Activities Related to Other Topics (2009- )

Kogan L, Octeau D, Amajoud Z, Abitbol J, Laskov I, Ferenczy A, Pelmus M, Eisenberg N, Kessous R, Lau S, Yasmeen A, Gotlieb WH, Salvador S.
 Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors.(Free PMC Article)
Gynecol Oncol Rep. 2018 Mar 19;24:43-47.

El-Zein M, Bouten S, Louvanto K, Gilbert L, Gotlieb W, Hemmings R, Behr MA, Franco EL; CASSIS Study Group, Liang V, Martins C, Duarte S, Sarban N, Geddes P, Massa A, Samios K, Aboufadl S, Verdon S, Pereria C, Lacroix I.
Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
Gynecol Oncol. 2018 Apr 17. [Epub ahead of print]

Le Page C, Rahimi K, Köbel M, Tonin PN, Meunier L, Portelance L, Bernard M, Nelson BH, Bernardini MQ, Bartlett JMS, Bachvarov D, Gotlieb WH, Gilks B, McAlpine JN, Nachtigal MW, Piché A, Watson PH, Vanderhyden B, Huntsman DG, Provencher DM, Mes-Masson AM.
 Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers.(Free PMC Article)
BMC Cancer. 2018 Mar 27;18(1):347.

Kessous R, Octeau D, Klein K, Tonin PN, Greenwood CMT, Pelmus M, Laskov I, Kogan L, Salvador S, Lau S, Yasmeen A, Gotlieb WH.
Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer.
Gynecol Oncol. 2018 Mar;148(3):553-558.

How JA, O'Farrell P, Amajoud Z, Lau S, Salvador S, How E, Gotlieb WH.
Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis.
Minerva Ginecol. 2018 Apr;70(2):194-214.

Piedimonte S, Leung A, Zakhari A, Giordano C, Tellier PP, Lau S.
Impact of an HPV Education and Vaccination Campaign among Canadian University Students.
J Obstet Gynaecol Can. 2018 Apr;40(4):440-446.

Philip CA, Laskov I, Beauchamp MC, Marques M, Amin O, Bitharas J, Kessous R, Kogan L, Baloch T, Gotlieb WH, Yasmeen A.
 Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors. (Free Article)
BMC Cancer. 2017 Sep 8;17(1):638.

Hoskins PJ, Gotlieb WH.
 Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature. (Free Article)
CA Cancer J Clin. 2017 Nov;67(6):493-506.

Blank N, Laskov I, Kessous R, Kogan L, Lau S, Sebag IA, Gotlieb WH, Rudski L.
Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin.
Cancer Chemother Pharmacol. 2017 Oct;80(4):737-743.

Kogan L, Laskov I, Amajoud Z, Abitbol J, Yasmeen A, Octeau D, Fatnassi A, Kessous R, Eisenberg N, Lau S, Gotlieb WH, Salvador S.
Dose dense carboplatin paclitaxel improves progression free survival in patients with endometrial cancer.
Gynecol Oncol. 2017 Oct;147(1):30-35.

How J, Boldeanu I, Lau S, Salvador S, How E, Gotlieb R, Abitbol J, Halder A, Amajoud Z, Probst S, Brin S, Gotlieb W.
Unexpected locations of sentinel lymph nodes in endometrial cancer.
Gynecol Oncol. 2017 Oct;147(1):18-23.

Holloway RW, Abu-Rustum NR, Backes FJ, Boggess JF, Gotlieb WH, Jeffrey Lowery W, Rossi EC, Tanner EJ, Wolsky RJ.
Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.
Gynecol Oncol. 2017 Aug;146(2):405-415.

Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S.
Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.
Prev Med. 2017 May;98:5-14.

Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S.
Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.
Prev Med. 2017 May;98:15-20.

Koushik A, Grundy A, Abrahamowicz M, Arseneau J, Gilbert L, Gotlieb WH, Lacaille J, Mes-Masson AM, Parent MÉ, Provencher DM, Richardson L, Siemiatycki J.
Hormonal and reproductive factors and the risk of ovarian cancer.
Cancer Causes Control. 2017 May;28(5):393-403.

Greenwald ZR, Huang LN, Wissing MD, Franco EL, Gotlieb WH.
 Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?(Free Article)
Cancer. 2017 May 1;123(9):1545-1554.

How J, Gauthier C, Abitbol J, Lau S, Salvador S, Gotlieb R, Pelmus M, Ferenczy A, Probst S, Brin S, Fatnassi A, Gotlieb W.
Impact of sentinel lymph node mapping on recurrence patterns in endometrial cancer.
Gynecol Oncol. 2017 Mar;144(3):503-509.

Kessous R, Laskov I, Abitbol J, Bitharas J, Yasmeen A, Salvador S, Lau S, Gotlieb WH.
Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer.
Gynecol Oncol. 2017 Mar;144(3):474-479.

Black A, Kyriacou J, Drummond N, Power J, Maheu C.
 Fear of cancer recurrence: A study of the experience of survivors of ovarian cancer(Open Access)
Canadian Oncology Nursing Journal. (2017) 27(3): 236-50.

Béland F, Galand C, Fletcher JD, Gotlieb WH, Abitbol J, Julien D.
Defining care trajectories: The example of endometrial cancer.
Journal of Cancer Policy, 2017. 12: p. 21-27.

Hoskins P, Gotlieb W
Ovarian Cancer Screening: UKCTOCS trial
Lancet (2016) 387: 2602-3

Laskov I, Beauchamp MC, Amin O, Nader P, Amber Y, Gotlieb WH.
Metformin Increases E-cadherin in Tumors of Diabetic Patients with Endometrial Cancer and
Suppresses EMT (Epithelial-Mesenchymal-Transition) in Endometrial Cancer Cell Lines
Int J Gynecol Cancer (2016) 26:1213-21

Sun P, Wu Q, Ruan G, Zheng X, Song Y, Zhun J, Wu L, Gotlieb WH
Expression patterns of maspin and mutant p53 are associated with the development of
gestational trophoblastic neoplasia
Oncol Lett. 2016 Nov; 12(5): 3135–3142.

Del Campo JM, Birrer M, Davis C, Fujiwara K, Gollerkeri A, Gore M, Houk B, Lau S, Poveda A, González-Martín A, Muller C, Muro K, Pierce K, Suzuki M, Vermette J, Oza A.
A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer.
Gynecol Oncol. 2016 Jul;142(1):62-69.

Bernardini MQ, Gien LT, Lau S, Altman AD, Gilks B, Ferguson SE, Köbel M, Samouëlian V, Wesa M, Cameron A, Nelson G, Han G, Clarke B, Ho TC, Panzarella T, Atenafu EG, McAlpine JN.
Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC).
Gynecol Oncol. 2016 Apr;141(1):148-54.

Altman AD, Ferguson SE, Atenafu EG, Köbel M, McAlpine JN, Panzarella T, Lau S, Gien LT, Gilks B, Clarke B, Cameron A, Nelson G, Han G, Samouëlian V, Ho TC, Louie K, Bernardini MQ.
Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers.
Gynecol Oncol. 2015 Nov;139(2):268-74.

Amin O, Beauchamp MC, Abou Nader P, Laskov I, Iqbal S, Philip CA, Yasmeen A, Gotlieb WH.

Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors.
BMC Cancer (2015) 15: 817

Hoskins PJ; Fung-Kee-Fung M; Miller D; Gotlieb W.

Time for a level playing field: inequalities in regulatory/approval processes-the example of bevacizumab in epithelial ovarian cancer.

J Clin Oncol. (2015) 33(14):1539-42.

How JA; Abitbol J; Lau S; Gotlieb WH; Abenhaim HA.

The impact of qualitative research on gynaecologic oncology guidelines.

J Obstet Gynaecol Can. (2015) 37(2):138-44.

How J; Lau S; Gotlieb WH
Current role of sentinel lymph node mapping in endometrial cancer.
Indian Journal of Gynecologic Oncology.
November 2015. DOI: 10.1007/s40944-015-0030-4

How J; Gotlieb WH; Press JZ; Abitbol J; Pelmus M; Ferenczy A; Probst S; Gotlieb R; Brin S; Lau S.

Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer.

Gynecologic Oncology. (2015) 137(3):436-42.

How J, Gotlieb WH
Sentinel lymph nodes evaluation in endometrial cancer. In “Uterine Cancer: Diagnosis& Management (2015) Springer Verlag. E. Dinesh Editor

Huang LN, Lau S, Gotlieb WH
Poor outcomes after conservative management for low-grade apparent early-stage endometrial cancer.
ObsetGynecol (2015) May 125: 106

Marques M, Beauchamp MC, Fleury H, Laskov I, Qiang S, Pelmus M, Mes-Masson AM, Gotlieb WH, Witcher M.

Chemotherapy reduces PARP1 in solid tumors: implications for future clinical trials involving PARP inhibitors.
BMC Cancer (2015) 13: 217

Oza AM, Cook AD, Pfisterer J et al.
Standard chemotherapywith or without bevacizumab for women with newly diagnosed ovarian cancer (ICON 7): overall survival results of a phase 3 randomized trial.
Lancet Oncol (2015) 16: 928-36

Rabinovich A; Bernard L; Niazi TM; Ramanakumar AV; Gotlieb WH; Lau S; Bahoric B.

Para-aortic and Pelvic Radiotherapy, an Effective and Safe Treatment in Advanced-stage Uterine Cancer.

Anticancer Research. (2015) 35(5):2893-900.

Rabinovich A, Bernard L, Ramanakumar AV, Stroian G, Gotlieb WH, Lau S, Bahoric B.
Para-aortic and pelvic extended-field radiotherapy for advanced-stage uterine cancer: dosimetric and toxicity comparison between the four-field box and intensity-modulated techniques.
CurrOncol. 2015 Dec;22(6):405-1.

Rabinovich A; Ramanakumar AV; Lau S; Gotlieb WH.

Prolonged pegylated liposomal doxorubicin treatment for recurrent pelvic cancers: a feasibility study.

Acta Obstetricia et Gynecologica Scandinavica. (2015) 94(7):776-80.

Singh SS; Scott S; Bougie O; Leyland N; SOGC Clinical Practice-Gynaecology Committee; Leyland N; Wolfman W; Allaire C; Awadalla A; Bullen A; Burnett M; Goldstein S; Lemyre M; Marcoux V; Potestio F; Rittenberg D; Singh SS; Yeung G; GOC Executive Committee; Hoskins P; Miller D; Gotlieb W; Bernardini M; Hopkins L

Technical update on tissue morcellation during gynaecologic surgery: its uses, complications, and risks of unsuspected malignancy.[Erratum appears in J Obstet Gynaecol Can. 2015 Feb;37(2):107]

Journal of Obstetrics & Gynaecology Canada: JOGC. (2015) 37(1):68-81.

Laskov I, Drudi L, Beauchamp MC, Yasmeen A, Ferenczy A, Pollak M, Gotlieb WH.

Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer.

Gynecol Oncol. (2014) 134: 607-14

Tsoref D, Welch S, Lau S, Biagi J, Tonkin K, Martin LA, Ellard S, Ghatage P, Elit L, Mackay HJ, Allo G, Tsao MS, Kamel-Reid S, Eisenhauer EA, Oza AM.
Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer.
Gynecol Oncol. 2014 Nov;135(2):184-9.

Le Page C, Köbel M, de Ladurantaye M, Rahimi K, Madore J, Babinszky S, Bachvarov DR, Bachvarova M, Beauchamp MC, Cass CE, Chadwick D, Colleen C, Damaraju S, Dufour J, Gotlieb WH, Kalloger SE, Portelance L, McAlpine JN, Matte I, Piché A, Shaw P, Roehrl MH, Vanderhyden BC, Watson PH, Huntsman DG, Provencher DM, Mes-Masson AM.

Specimen quality evaluation in Canadian biobanks participating in the COEUR repository.

Biopreserv Biobank. (2013) 11:83-93.

Drudi L, Press J, Lau S, Gotlieb S, How S, Drummond N, Brin S, Deland S, Gotlieb W.

Vaginal vault dehiscence after robotic hysterectomy in patients with gynecologic cancers: Prospective evaluation and literature review.

Int J Gynecol Cancer (2013) 23:943-50

Niu X, Rajanbabu A, Delisle M, Peng F, Vijaykumar DK, Pavithran K, Feng Y, Lau S, Gotlieb WH, Press J.

Brain metastases in women with epithelial ovarian cancer: multimodal treatment including surgery or gamma-knife radiation is associated with prolonged survival

J Obstet Gynaecol Can (2013) 35:816-22

Gotlieb WH

Fertility preserving treatments in endometrial cancer: The unanswered questions.

Gynecol Oncol (2013) 129: 1-2

Zhang J, Shi Y, Lalonde E, Li L, Cavallone L, Ferenczy A, Gotlieb WH, Foulkes WD, Majewski J.

Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient.

BMC Cancer (2013) 13:146.

Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM, Moysich K, Doherty JA, Felberg A, Miller D, Jordan SJ, Goodman MT, Lurie G, Chang-Claude J, Rudolph A, Kjær SK, Jensen A, Høgdall E, Bandera EV, Olson SH, King MG, Rodriguez-Rodriguez L, Kiemeney LA, Marees T, Massuger LF, van Altena AM, Ness RB, Cramer DW, Pike MC, Pearce CL, Berchuck A, Schildkraut JM, Whittemore AS.

Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.

Int J Epidemiol. 2013; 42 (2): 579-589.

Tone A, Salvador S, Finlayson S,Tinker A, Kwon J, Lee C, Cohen T, Ehlen T, Lee M, Carey M, Heywood M, Pike J, Hoskins P, Stuart G, Swenerton K, Huntsman D Gilks B, Miller D, McAlpine J. The Role of the Fallopian Tube in Ovarian Cancer.

Clin Adv Hematol Oncol, 2012; 10 (5): 296-306.

Crawford B, Piault E, Gotlieb W, Joulain F.

Development and validation of the self-completed ascites impact measure to understand patient

motivation for requesting a paracentesis.

Patient Relat Outcome Meas. (2012) 3:21-30.

How J, Lau S, Press J, Ferenczy A, Pelmus M, Stern J, Probst S, Brin S, Drummond N, Gotlieb W.

Accuracy of sentinel lymph node detection following intra-operative cervical injection for endometrial cancer: A prospective study.

Gynecol Oncol. (2012) 127 (2): 673-7.

Hopkins L, Carrier M, Plante M, Luna V, Gotlieb W, Rambout L.

Surgical venous thromboprophylaxis: a cross-sectional survey of canadian gynaecologic oncologists.

J Obstet Gynaecol Can. 2012 34(7):673-7.

Press JZ, Gotlieb WH.

Controversies in the treatment of early stage endometrial carcinoma.

Obstet Gynecol Int. 2012;2012:578490. Epub 2012 Mar 26

He G, Holcroft CA, Beauchamp MC, Yasmeen A, Ferenczy A, Kendall-Dupont J, Mes-Masson AM, Provencher D, Gotlieb WH.

Combination of serum biomarkers to differentiate malignant from benign ovarian tumors.

J Obstet Gynaecol Can (2012) 34: 567-574

Lau S, Vaknin Z, Agnihotram VR, Franco E, Gotlieb R, How J, Halliday D, Gotlieb WH..

Outcomes and cost following the introduction of a robotics program for endometrial cancer surgery Obstet. Gynecol(2012) 119 (4): 1-10

Gotlieb WH, Amant F, Advani F, Goswami C, Hirte H, Provencher D, Somani D, Yamada D, Tamby J, Vergote I..

Intravenous aflibercept (VEGF Trap) for the treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer : results of a phase II, randomized, double-blind, placebo-controlled study.

Lancet Oncology 2012 13(2):154-62

Fu L, Lau S, Roy I, Ferenczy A.
Phyllodes tumor with malignant stromal morphology of the vulva: a case report and review of the literature.
Int J Gynecol Pathol. 2011 Mar;30(2):198-202.

Perri T, Korach J, Gotlieb WH, Beiner M, Meirow D, Friedman E, Ferenczy A, Ben-Baruch G.

Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved.

Int J Gynecol Cancer. 2011 Jan;21(1):72-8.

Chen X, Zhang H, Aravindakshan JP, Gotlieb WH, Sairam MR

Anti-proliferative and pro-apoptotic actions of a novel human and mouse ovarian tumor-associated

gene OTAG-12: downregulation, alternative splicing and drug sensitization.

Oncogene. 2011 30 (25): 2874-87

Yasmeen A, Beauchamp MC, Piura E, Segal E, Pollak M, Gotlieb WH

Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins.

Gynecol Oncol. 2011 121 (3) 492-8

Oza AM, Elit L, Tsao MS, Kamel-Reid S, Biagi J, Provencher DM, Gotlieb WH, Hoskins PJ, Ghatage P, Tonkin KS, Mackay HJ, Mazurka J, Sederias J, Ivy P, Dancey JE, Eisenhauer EA.

Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group.

J Clin Oncol. 2011 Aug 20;29(24):3278-85

Segal ED, Yasmeen A, Beauchamp MC, Rosenblatt J, Pollak M, Gotlieb WH.

Relevance of the OCT1 transporter to the antineoplastic effect of biguanides.

Biochem Biophys Res Commun. 2011 414 (4): 694-9

Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey

MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stähle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK, Oza AM, ICON 7 investigators.

A phase 3 trial of bevacizumab in ovarian cancer.

N Engl J Med. (2011) 365(26):2484-96

Reiss A, Gotlieb WH

Molecular Basics of Gynecologic Cancers. In “Textbook of Gyneaecological Oncology”, 2nd edition (2011) ESGO, A Ayhan, N Reed and M Gultekin editors

Reiss A, Gotlieb WH

On the origin of ovarian and endometrial cancers: molecular profiling of gynecologic cancers. In “Recent advances in gynaecologic oncology. (2011) Jaypee brothers,India, Dilip Kumar Dutta eidtor.

Beauchamp MC, Yasmeen A, , Knafo A, Gotlieb WH.

Targeting insulin and insulin-like growth factor (IGF) pathways in epithelial ovarian cancer. Journal of Oncology. (2010) 257058 : 1-11

Perri T, Rahimi K, Ramanakumar AV, Wou K, Pilavdzic D, Franco EL, Gotlieb WH, Ferenczy A. Are endometrial polyps true cancer precursors?

Am J Obstet Gynecol (2010) 203: 232

Hauspy J, Jimenez JW, Rosen B, Gotlieb W, Plante M

Laparoscopic surgery for endometrial cancer

J Obst Gynecol Can (2010) 32:570-9

Henry M, Cohen SR, Lee V, Sauthier P, Provencher D, Drouin P, Gauthier P, Gotlieb W et al.

The meaning-making intervention (MMI) appears to increase meaning in life in advanced ovarian cancer: a randomized controlled pilot study

Psychooncology (2010) 19 (12): 1340-7

Gotlieb WH

Intraperitoneal chemotherapy: why the fuzz?

Int J Gynecol Cancer (2010) 20: S14-6

Salvador S.

Tubal ligation and risk of invasive epithelial ovarian cancer.

MSc thesis. Stanford University, Stanford, California. 2010. Print.

Le T, Giede C, Salem S, Lefebvre G, Rosen B, Bentley J, Kupets R, Power P, Renaud MC, Bryson P, Davis DB, Lau S, Lotocki R, Senikas V, Morin L, Bly S, Butt K, Cargill YM, Denis N, Gagnon R, Hietala-Coyle MA, Lim KI, Ouellet A, Raciot MH; Society of Obstetricians and Gynaecologists of Canada.
Initial evaluation and referral guidelines for management of pelvic/ovarian masses.
J Obstet Gynaecol Can. 2009 Jul;31(7):668-80.

Vaknin Z, Gotlieb WH

Molecular Basics of Gynecologic Cancers. In “Textbook of Gyneaecological Oncology”, 1st edition (2009) ESGO, A Ayhan, N Reed and M Gultekin editors.

Perri T, Gotlieb WH.

Pathogenesis of fallopian tube cancers In 'The Fallopian Tube' (2009) 611-624. Anshan Ltd, Kent, United Kingdom,Allahbadia GN, Saridogan E, Djahanbakhch O, editors.

Tunitsky L, Bruchim I, Lau S, Denschlag D, Gotlieb WH.

Post-operative ascites of unknown etiology in early stage endometrial cancer.

Eur J Surg Oncol (2009) 35 : 785-786

Beauchamp MC, Knafo A, Yasmeen A, Carboni JM, Gottardis MM, Pollak MN, Gotlieb WH.

BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide.

Gynecol. Oncol. (2009) 115: 193-8

Vaknin Z, Gotlieb WH, Arseneau J, Ferenczy A

Papillary serous carcinoma in situ in ovarian endometriosis in a MSH2 carrier

Int J Gynaecol Obstet (2009) 107: 68-69

Bruchim I, Israeli O, Salaheddin MS, Aviram-Goldring A, Rienstein S, Friedman E, Ben-Baruch G, Gotlieb WH

Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma

Cancer Genetics and Cytogenetics. (2009)190(2):66-70

Salvador S, Cundiff GW, Simpson ML.

Dinoprostone Vaginal Insert for Labour Induction: A Comparison of Outpatient and Inpatient Settings.

J Obstet Gynaecol Can, 2009; 31 (11): 1028-34.

Salvador S, Gilks B, Köbel M, Huntsman D, Rosen B, Miller D.

The Fallopian Tube: Primary Site of Most Pelvic High-Grade Serous Carcinomas.

Int J Gynecol Cancer, 2009; 19: 58-64.

Academic Activities Related to Other Topics (2009- )

Tracing decision-making processes in healthcare.
Tracing decision making processes amongst Gyn-Onc in function of gender.
Cutting through surgical decisions in gyn-onc: staff vs. residents.
Biennial International Gynecologic Oncology Society Meeting, Lisbon, Portugal, October 2016

How do MD’s Make Decisions.
Annual General Meeting, Society of Gynecologic Oncology of Canada, Vancouver, June 2016.

Exploring New Regulators of DNA Repair Pathways as Predictors of Response to Chemotherapy
and Overall Prognosis in Ovarian Cancer.
International Symposium on Hereditary Breast and Ovarian Cancer, Montreal, May 2016

Sequential therapeutic targeting of ovarian cancer harboring dysfunctional BRCA 1.
Exploring DNA repair genes expression levels following chemotherapy in high grade serous cancers.
HBOC meeting, Montreal April 2016

Borderline tumors: fertility preservation and pregnancy outcomes
AGOICON, Hyderabad, India, Nov. 2015


outcomes following conservative management for low grade, apparent early stage endometrial cancer.
ACOG meeting, ACOG meeting, San Francisco, May 2015



Page last updated on 

We always seek feedback to make our site better.